No Data
Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro, Company's Antibiotic-Eluting BioEnvelope for Implantable Devices
Elutia Celebrates First Year
Cantor Fitzgerald Maintains Elutia(ELUT.US) With Buy Rating, Maintains Target Price $10
Express News | Elutia Announces First Patient Implant Of EluPro
Elutia Announces First Patient Implant of EluPro, the World's First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators
Elutia to Participate in Upcoming Investor Conferences
No Data
No Data
Moomoo Lily : Hi, @Moomoo Buddy please assist, thanks!
Jaguar8 : It’s not halted. It is actually closed for trading this after hours
Moomoo Buddy : Dear client, this counter is tradeable, if you can not buy it, please contact customer service, thank you.